Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
FDA Approves New Adjuvant Treatment Option for Patients at High Risk of Kidney Cancer Recurrence
The FDA has approved the combination of belzutifan (Welireg) and pembrolizumab (Keytruda) as adjuvant treatment for adults with clear cell renal cell carcinoma who are at intermediate-high or high risk of recurrence following surgery.
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
